These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study. Watala C; Ulicna O; Golanski J; Nocun M; Waczulíková I; Markuszewski L; Drzewoski J Blood Coagul Fibrinolysis; 2006 Mar; 17(2):113-24. PubMed ID: 16479193 [TBL] [Abstract][Full Text] [Related]
24. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension. Islim IF; Bareford D; Beevers DG Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379 [TBL] [Abstract][Full Text] [Related]
25. Reproducibility of platelet function testing. Hevelow ME; McKenzie SM; Siegel JE Lab Hematol; 2007; 13(2):59-62. PubMed ID: 17573283 [TBL] [Abstract][Full Text] [Related]
26. Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)]. Shenkman B; Einav Y; Salomon O; Varon D; Savion N Platelets; 2008 Sep; 19(6):440-6. PubMed ID: 18925512 [TBL] [Abstract][Full Text] [Related]
27. Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction. Jámbor C; Weber CF; Gerhardt K; Dietrich W; Spannagl M; Heindl B; Zwissler B Anesth Analg; 2009 Jul; 109(1):25-31. PubMed ID: 19439684 [TBL] [Abstract][Full Text] [Related]
28. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Sibbing D; Braun S; Jawansky S; Vogt W; Mehilli J; Schömig A; Kastrati A; von Beckerath N Thromb Haemost; 2008 Jan; 99(1):121-6. PubMed ID: 18217143 [TBL] [Abstract][Full Text] [Related]
29. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents. Lages B; Weiss HJ Thromb Haemost; 1981 Apr; 45(2):173-9. PubMed ID: 6789496 [TBL] [Abstract][Full Text] [Related]
30. Point-of-care platelet function tests: detection of platelet inhibition induced by nonopioid analgesic drugs. Scharbert G; Gebhardt K; Sow Z; Duris M; Deusch E; Kozek-Langenecker S Blood Coagul Fibrinolysis; 2007 Dec; 18(8):775-80. PubMed ID: 17982319 [TBL] [Abstract][Full Text] [Related]
31. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100. Cesar JM; de Miguel D; García Avello A; Burgaleta C Am J Clin Pathol; 2005 May; 123(5):772-7. PubMed ID: 15981818 [TBL] [Abstract][Full Text] [Related]
32. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678 [TBL] [Abstract][Full Text] [Related]
33. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy. Christie DJ; Kottke-Marchant K; Gorman RT Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773 [TBL] [Abstract][Full Text] [Related]
34. The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Bath PM Thromb Haemost; 1993 Oct; 70(4):687-90. PubMed ID: 8115997 [TBL] [Abstract][Full Text] [Related]
35. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study. Angiolillo DJ; Bernardo E; Palazuelos J; Desai B; Weisberg I; Alfonso F; Guzman LA; Hernández-Antolin R; Zenni MZ; Macaya C; Fernandez-Ortiz A; Bass TA Thromb Haemost; 2008 Jan; 99(1):161-8. PubMed ID: 18217149 [TBL] [Abstract][Full Text] [Related]
36. Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug. Labarthe B; Théroux P; Angioï M; Ghitescu M J Am Coll Cardiol; 2005 Aug; 46(4):638-45. PubMed ID: 16098428 [TBL] [Abstract][Full Text] [Related]
37. Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin. Takahashi S; Ushida M; Komine R; Shimizu A; Uchida T; Ishihara H; Shibano T; Watanabe G; Ikeda Y; Murata M Thromb Res; 2007; 119(4):517-24. PubMed ID: 16793119 [TBL] [Abstract][Full Text] [Related]
38. Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target. Gurbel PA; Antonino MJ; Bliden KP; Dichiara J; Suarez TA; Singla A; Tantry US Platelets; 2008 Dec; 19(8):595-604. PubMed ID: 19012177 [TBL] [Abstract][Full Text] [Related]
40. A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke. Nakajima S; Noguchi T; Taka T; Ueda T; Kaizu K; Fukamizu M; Fujita S; Tabuchi M; Yamamoto J Platelets; 2000 Dec; 11(8):459-66. PubMed ID: 11177445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]